Life Sciences and Innovation
Meet the Team

Emma Goodford

Partner - Head of Life Sciences and Innovation - Occupational, Leasing and Development

Emma shares her knowledge of the Golden Triangle markets across a range of client projects. She is working with Brockton Everlast on the planned development of 10 acres in the heart of Cambridge Science Park. A recent fact finding trip to the US included tours of MIT/Kendall Square, Stanford Research Park and Berkeley, which are great places to see how ecosystems thrive, adjacencies create value and amenity, and service is king.

Also, in Cambridge she has been the consultant advising on the proposals, in public consultation, for the potential expansion of the Cambridge Biomedical Campus. In London, Emma is part of the Knight Frank team advising HIG and Lateral on a planned speculative lab development at Cavell Street, Whitechapel which will deliver almost 145,000 sq ft of bespoke lab enabled space in 2025/6.

Philip Hobley

Partner - London Life Sciences

Phil is working across central London advising clients on the evolving Life Science sector across the clusters. Live mandates include projects in the Knowledge Quarter for Clearbell, Ashby Capital and Native Land.

Mark Routledge

Partner - Life Sciences and Capital Markets

Mark advised Brookfield Asset Management on the purchase of the Atom Portfolio in 2021, which comprised 5 science and innovation parks for £714m - the largest transaction in the sector in the last 24 months. Other assets Mark has advised on include Colworth Science Park, Granta Park, Chesterford Research Park, Oxford Business Park, Cambridge Science Park and Cambridge Research Park.

As well as living in Cambridge, Mark previously worked for MEPC and was involved in the inception and master planning of Granta Park still widely regarded as one of the best Life Science Park’s in the UK. Mark’s experience covers leasing, development, asset management, pre-purchase underwriting and strategic long-term advice and therefore is uniquely positioned to advise on the sector. A selection of clients Mark has worked with include Stanhope, Cadillac Fairview, Brookfield Asset Management, RLAM, Napp Pharmaceuticals, GSK, Blackstone, Aviva Investors and Columbia Threadneedle.

Andrew Harrison

Partner - Life Sciences Capital Markets and Development

Andrew has over 15 years of experience providing clients with transactional and development consultancy advice across London. Advisory roles include underwriting and strategic buyside acquisition advice on the Department of Health Whitechapel Life Science Estate, Guys and St Thomas’ Snowsfields site, and the Royal Street Estate, Waterloo.

Freddie Owen

Partner - Life Sciences and Capital Markets

Freddie is a partner within the Capital Markets department specialising in the acquisition, disposal and financing of major commercial investments and developments with a focus on Life Sciences. Freddie has extensive experience in appraising investment & development opportunities and advises a range of UK and International clients on developing investment strategies. Freddie has recently advised Kadans Science partner on their acquisition of the Oxford Biomedica HQ in Oxford and historically acted on the disposals of Colworth Science Park, Abbot Laboratories HQ and the Sanofi HQ.

Henry Wyld

Partner - Life Sciences and Capital Markets

Henry is working with Capital Markets clients across the Arc and advised L&G on the sale of 214-240 Cambridge Science Park. Henry works closely with clients including British Land, Runlabs, Angelo Gordon and Mission Street.

Jennifer Townsend

Partner - Research Life Sciences

Jen is the author of the quarterly Life Sciences and Innovation Insight Report which tracks sector performance, events shaping the sector and leasing, development and investment activity. She also evaluates occupier demand across core life sciences clusters. This involves identifying emergent sub-sectors, proactively finding the most relevant occupiers for schemes and developing an in-depth understanding of occupiers through profiling.

Jen is also responsible for thematic research focused on getting ahead of the macro and occupier trends shaping the sector and its real estate requirements.

Tom Coaker

Associate - Life Sciences and Capital Markets

Working closely with Mark Routledge, Tom advised Brookfield Asset Management on the purchase of the Atom Portfolio in 2021 which comprised 5 science and innovation parks for £714m, the largest transaction in the sector in the last 24 months.

Most recently he has worked with Cadillac Fairview and Stanhope Plc advising on the purchase of 194-198 Cambridge Science Park. Other assets Tom has advised on include Oxford Business Park and Cambridge Research Park. A selection of clients Tom has worked with include Brookfield Asset Management, RLAM, Cadillac Fairview and Stanhope Plc.

Neil Mclocklin

Partner - Occupier Consultancy - Life Sciences and Innovation

Neil is responsible for Strategic Consulting within Knight Frank, working with businesses to align real estate to strategy. He has over 30 years of consultancy expertise, mainly focused on occupier portfolio, location and workplace strategies, across all sectors and with a strong focus on Life Sciences, where clients include Bayer, Cambridge Science Park – UK, Hydro-genics, London Watford Innovation and Incubation hub, Monheim Science Park - Germany, Novartis, Oxford - Harwell Science Campus, Plus X Innovation Hub - Brighton, RINA, Roche, Socotec, Shionogi, Takeda, Teva, UCB, AstraZeneca and GSK.

Over the last 10 years, he has been increasingly asked to turn his occupier lens around to help developers and investors re-position their assets or develop market strategies, particularly focus on tech and innovation. He has Master's degrees that span business strategy, technology, real estate and change management, at Universities that include UCL, Cass Business School and University of Southern California.

Michael Crowe

Partner - Valuation and Advisory - Life Sciences

Michael has significant experience in valuing Life Science assets having valued over £4bn across the UK in the last 24 months including schemes in Oxford, Edinburgh, and the Golden Triangle.

Iain Keys

Office Head, Cambridge – UK Life Sciences and Innovation

Iain has been working in the life science sector for the last four years, focusing on development consultancy and investment. Based in Cambridge, Iain is embedded in the market and has a deep understanding of user requirements, provision of space and the ecosystem across the Arc. Iain has provided development consultancy advice on Howbery Park, near Oxford, a £200m opportunity to create the UK’s first cluster focused on water, climate change and the environment, chaired a government advisory panel to assist the government on shaping policy to develop the Cambridge Oxford Arc as well as investment advice and winning asset management instructions for life science space. He has extensive experience in advising on the creation of joint ventures, long term strategic advice, working with overseas investors and sustainability/green energy initiatives. Having worked as a consultant and client, he has a valuable understanding of client requirements and fund management. Over the last three years he has also worked on film studio development and is seen as a leading consultant in the sector. Clients include Biomed, IQHQ, TusPark, HR Wallingford.